Select region
Submit
Menu
  • Products and Solutionsmore
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Servicesmore
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insightsmore
    • Articles
    • Events
    • Getinge Experience Center
    • Research funding requests
    • Idea and invention submission

    • Insights main page →
  • Companymore
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • History

    • Company main page →
    • News
    • Legal Information
    • Instructions For Use / Patient Information
    • Product Catalog
    • COVID-19 Resource Center
    • Investors
    • Careers
  • Contact
  • India (English)
    • Global
      • International (English)
    • EMEA
      • Sverige (Svenska)
      • Deutschland (Deutsch)
      • France (Français)
      • United Kingdom / Ireland (English)
      • Italia (Italiano)
      • Türkiye (Türkçe)
      • Polska (polski)
      • Россия (русский)
      • Middle East (English)
      • South Africa (English)
      • Spain (Español)
      • Denmark (Dansk)
      • Norge (Norsk)
      • Suomi (Suomalainen)
      • French Speaking Africa (Français)
    • Americas
      • United States (English)
      • Brazil (Português)
      • Canada (English)
      • Latin America (Español)
    • Asia
      • 日本 (日本語)
      • 中国 (中文)
      • 한국어(대한민국)
      • South East Asia (English)
      • India (English)
    • Oceania
      • Australia / New Zealand (English)
  • Products and Solutions
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Services
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insights
    • Articles
    • Events
    • Getinge Experience Center
    • Research funding requests
    • Idea and invention submission

    • Insights main page →
  • Company
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • History

    • Company main page →
  • Contact
  • Start
  • Products and Solutions
  • Intensive Care
  • Extracorporeal Membrane Oxygenation (ECMO)

Getinge ECMO solutions:
Gain time for life

Getinge ECMO - ICU Clip

With critically ill patients, there’s no time for delay.  

Cardiogenic shock, acute respiratory distress syndrome, septic shock or pulmonary embolisms are conditions that can become life-threatening. Patients with severe cardiac and/or pulmonary failure require immediate support to maintain gas exchange and end-organ perfusion.

Extracorporeal Membrane Oxygenation (ECMO) provides clinicians a powerful option to help stabilize blood circulation and/or respiratory functions of affected patients. [1]

ECMO can provide time for the clinician to treat the underlying cause.

Gain time for life with Getinge ECMO solutions.

Explore our products
Gain time to recover

How can Extracorporeal Membrane Oxygenation (ECMO) help your patients?

For critically ill patients, time is precious. ECMO buys additional time, supporting organ perfusion, while the patient heals or further treatments are applied. This gives caregivers more time to optimize the patient's therapy while easing the body’s workload.

ECMO can be used for a wide range of indications in intensive care, emergency medicine, cardiology, cardiac surgery, and patient transport.

Clinicians trust Getinge’s knowledge and experience

Getinge ECMO systems are small and lightweight heart-lung support systems. Although Extracorporeal Membrane Oxygenation (ECMO) is not a therapy itself, it acts as a bridge to further treatment, recovery or transplantation. This gives caregivers more time to optimize the patient's therapy while easing the body’s workload. 

Getinge ECMO systems are intended for intra-hospital and some also for inter-hospital patient transport. Even during transport, the portable systems allow adequate oxygenation of the patient and CO2 reduction to optimize organ perfusion.

 

Gain time for life.

Application areas and indications

ECMO offers a bridge to therapy for patients with a variety of medical conditions, including respiratory failure, ARDS, pulmonary embolism, cardiogenic shock, cardiac arrest, failure to wean from bypass after cardiac surgery, or as a bridge to transplantation or placement of a ventricular assist device.

 

Cardiac Applications

ECMO and Cardiogenic Shock

ECMO has become a life-saving tool to support patients with severe and refractory cardiogenic shock, either after myocardial infarction, cardiac surgery, myocarditis or intoxication.

eCPR and Cardiac Arrest

Annually, there are millions of cardiac arrest events all with low percent survival. Recent randomized controlled trials [2],[3] suggest extracorporeal cardiopulmonary resuscitation (eCPR) may provide a survival benefit in carefully selected patients with cardiac arrest.

Respiratory Applications

ECMO and Covid-19

Getinge ECMO solutions provide a resource for the care of patients with COVID-19, offering time for their damaged lungs to recover when mechanical ventilation is not enough.

ECMO and ARDS

Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) solutions can be a resource for the care of patients with severe Acute Respiratory Distress Syndrome (ARDS).

 

ECCO₂R and Respiratory Medicine

Extracorporeal Carbon Dioxide Removal (ECCO₂R) removes carbon dioxide (CO₂) from the blood using an extracorporeal circuit which facilitates the protection and recovery of the lungs.

ECMO transport with Cardiohelp

Gain time to act.

Related Articles

Covid-19 & PiCCO

The Italian experience: a practical advice

Professor Salvatore Grasso, Head of the Department of Anesthesia and Resuscitation at the Faculty of Medicine and Surgery of the University of Bari Aldo Moro Polyclinic, tells his story about the worst health care situation in Italy. Watch the video and learn what he experienced firsthand during the treatment of severely ill patients, at this time, infected by an unknown virus.

Read more

Hemodynamic parameter

The Value of Advanced Hemodynamic Monitoring

Beyond Basic - with advanced hemodynamic parameters. Learn more about blood pressure, blood flow, preload, afterload, contractility, and pulmonary edema parameters.

Read more

Training session with nurse looking at hemodynamic monitoring equipment

Understand hemodynamic data at a glance

Hemodynamic insights present valuable knowledge for physicians. In the OR, patients undergoing surgeries always benefit from close vigilance. Optimal perioperative fluid administration is the key for a successful recovery. In the ICU, the life of critically ill patient depends on the right decision for the next therapeutic step.

Read more

ARDS

ARDS

Acute respiratory distress syndrome (ARDS) is a serious lung condition that causes low blood oxygen. The incidence of ARDS varies widely.

Read more

Explore the ECMO product offering

Getinge offers a broad, high-end product portfolio for short-term or prolonged Extracorporeal Membrane Oxygenation (ECMO). It includes a choice of devices and consumables to provide individual extracorporeal heart and/or lung support, such as centrifugal pumps, oxygenators, heater units, tubing sets, catheters and cannulae.

Cardiohelp System

HLS Set Advanced

HLS Cannulae

Avalon Elite Catheter

HU 35 Heater Unit

Sprinter Cart

Rotaflow II System

PLS Set

Load more

All references

  1. 1. Extracorporeal Life Support Organization (ELSO); General Guidelines for all ECLS Cases; August, 2017

  2. 2. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial
    Randomized Controlled Trial JAMA. 2022 Feb 22;327(8):737-747. doi: 10.1001/jama.2022.1025.

    Prague OHCA
  3. 3. The ARREST trial Yannopoulos D, Bartos J, Raveendran G, Walser E, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020 Nov 12:S0140-6736(20)32338-2. doi: 10.1016/S0140-6736(20)32338-2. Epub ahead of print. PMID: 33197396 NCT03880565

    The ARREST trial – ECMO CPR
  4. 4. HLS Set Advanced in combination with HLS Cannulae with Bioline Coating can be used for up to 30 days in CE region.

You are now leaving Getinge.com. You might access content not managed by Getinge team, in that case Getinge can not be hold responsible of the content. 

I understand! Stay in Getinge.com

Our offer

  • Products and Solutions
  • Services

Support and tools

  • Insights
  • Events
  • Past Webinars
  • Instructions For Use/Patient Information
  • Security

Company

  • Investors
  • Careers
  • Corporate Governance
  • History
  • Legal Information
  • Privacy Policy
  • Website use disclaimer
  • Cookie Notice
  • Data Subject Request Form
Get in contact
India (English)
  • Global
    • International (English)
  • EMEA
    • Sverige (Svenska)
    • Deutschland (Deutsch)
    • France (Français)
    • United Kingdom / Ireland (English)
    • Italia (Italiano)
    • Türkiye (Türkçe)
    • Polska (polski)
    • Россия (русский)
    • Middle East (English)
    • South Africa (English)
    • Spain (Español)
    • Denmark (Dansk)
    • Norge (Norsk)
    • Suomi (Suomalainen)
    • French Speaking Africa (Français)
  • Americas
    • United States (English)
    • Brazil (Português)
    • Canada (English)
    • Latin America (Español)
  • Asia
    • 日本 (日本語)
    • 中国 (中文)
    • 한국어(대한민국)
    • South East Asia (English)
    • India (English)
  • Oceania
    • Australia / New Zealand (English)
India (English)
;

© 2023 Getinge │ Getinge and  Getinge_Logo_hz_RGB_neg.pngare trademarks or registered trademarks of Getinge AB, its subsidiaries or affiliates │All rights reserved.

May 2023

This information is aimed exclusively at healthcare professionals or other professional audiences and is for informational purposes only, is not exhaustive and therefore should not be relied upon as a replacement of the Instructions for Use, service manual or medical advice. Getinge shall bear no
responsibility or liability for any action or omission of any party based upon this material, and reliance is solely at the user’s risk.
Any therapy, solution or product mentioned might not be available or allowed in your country. Information may not be copied or used, in whole or in part, without written permission by Getinge.

This information is intended for an international audience outside the US.

Views, opinions, and assertions expressed are strictly those of the interviewed and do not necessarily reflect or represent the views of Getinge.

  • Products and Solutions
  • Services
  • Insights
  • Company
  • News
  • Legal Information
  • Instructions For Use / Patient Information
  • Product Catalog
  • COVID-19 Resource Center
  • Investors
  • Careers
  • Contact